Citigroup’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-7
Closed -$2K 7847
2018
Q4
$2K Hold
7
﹤0.01% 7524
2018
Q3
$2K Sell
7
-56
-89% -$16.8K ﹤0.01% 7623
2018
Q2
$21K Buy
63
+15
+31% +$4.94K ﹤0.01% 6906
2018
Q1
$12K Buy
+48
New +$14K ﹤0.01% 6985
2017
Q4
Sell
-30
Closed -$16K 7675
2017
Q3
$16K Sell
30
-20
-40% -$10.6K ﹤0.01% 6535
2017
Q2
$32K Buy
50
+38
+317% +$25.5K ﹤0.01% 6063
2017
Q1
$9K Sell
12
-132
-92% -$105K ﹤0.01% 6610
2016
Q4
$117K Buy
144
+53
+58% +$42.1K ﹤0.01% 5679
2016
Q3
$83K Buy
91
+23
+34% +$22.5K ﹤0.01% 5324
2016
Q2
$60K Buy
68
+19
+39% +$12.7K ﹤0.01% 5460
2016
Q1
$25K Sell
49
-94
-66% -$47.8K ﹤0.01% 6459
2015
Q4
$86K Sell
143
-38
-21% -$27.6K ﹤0.01% 5497
2015
Q3
$117K Buy
+181
New +$137K ﹤0.01% 4868

Other funds holding VIVS

Citigroup's VIVS Position: Q2 2026 in Review

Citigroup sold out of VivoSim Labs (VIVS) in Q2 2026, closing a stake of 6,504 shares — an estimated $9.3K sold.

Citigroup first reported a position in VIVS in Q3 2013 and held it in 36 quarters. The position peaked at $373K in Q4 2016. 26 funds tracked by Wall St. Rank hold VIVS as of Q2 2026.

  • Citigroup reported no remaining VivoSim Labs position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 6,504 VivoSim Labs shares in Q2 2026, an estimated $9.3K.
  • Citigroup first reported a position in VivoSim Labs in Q3 2013 and held it in 36 quarters.
  • Citigroup's VivoSim Labs position peaked at $373K in Q4 2016.
  • 26 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.